GSK Plc (GSK)
56.54
+0.55
(+0.98%)
USD |
NYSE |
Apr 02, 12:49
GSK Research and Development Expense (TTM) : 9.632B for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| AstraZeneca PLC | 13.84B |
| Biodexa Pharmaceuticals Plc | 5.234M |
| Novavax, Inc. | 338.72M |
| Mereo BioPharma Group Plc | 17.81M |
| BioNTech SE | 2.379B |